295 related articles for article (PubMed ID: 25046597)
1. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Dec; 34(13):1277-82. PubMed ID: 25046597
[TBL] [Abstract][Full Text] [Related]
2. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
3. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
[TBL] [Abstract][Full Text] [Related]
4. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
[TBL] [Abstract][Full Text] [Related]
5. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Wanapirak C; Sirichotiyakul S
Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy.
Tongprasert F; Wanapirak C; Tongsong T
Prenat Diagn; 2011 May; 31(5):430-3. PubMed ID: 21312197
[TBL] [Abstract][Full Text] [Related]
7. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Piyamongkol W; Tongprasert F; Srisupundit K; Luewan S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
[TBL] [Abstract][Full Text] [Related]
8. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
Srisupundit K; Piyamongkol W; Tongsong T
Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
[TBL] [Abstract][Full Text] [Related]
9. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity.
Srisupundit K; Piyamongkol W; Tongsong T
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):694-7. PubMed ID: 19350531
[TBL] [Abstract][Full Text] [Related]
10. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
[TBL] [Abstract][Full Text] [Related]
11. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation.
Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Prenat Diagn; 2014 Mar; 34(3):230-4. PubMed ID: 24318930
[TBL] [Abstract][Full Text] [Related]
12. Second-trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population-based study.
Wanapirak C; Piyamomgkol W; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P; Tongsong T
Prenat Diagn; 2018 Aug; 38(9):700-705. PubMed ID: 29927491
[TBL] [Abstract][Full Text] [Related]
13. Appearance of Abnormal Cardiothoracic Ratio of Fetuses with Hemoglobin Bart's Disease: Life Table Analysis.
Wanapirak C; Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Ultraschall Med; 2017 Oct; 38(5):544-548. PubMed ID: 28863410
[No Abstract] [Full Text] [Related]
14. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Sep; 34(9):864-9. PubMed ID: 24733401
[TBL] [Abstract][Full Text] [Related]
16. Fetal liver length measurement at mid-pregnancy among fetuses at risk as a predictor of hemoglobin Bart's disease.
Luewan S; Tongprasert F; Piyamongkol W; Wanapirak C; Tongsong T
J Perinatol; 2011 Mar; 31(3):157-60. PubMed ID: 20651692
[TBL] [Abstract][Full Text] [Related]
17. Fetal septum primum excursion (SPE) and septum primum excursion index (SPEI) as sonomarkers of fetal anemia: using hemoglobin Bart's fetuses as a study model.
Sirilert S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2016 Jul; 36(7):680-5. PubMed ID: 27174768
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Performances of Middle Cerebral Artery Peak Systolic Velocity and Cardiothoracic Diameter Ratio in Predicting Fetal Anemia: Using Fetal Hemoglobin Bart's Disease as a Study Model.
Chankhunaphas W; Tongsong T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P
Fetal Diagn Ther; 2021; 48(10):738-745. PubMed ID: 34794140
[TBL] [Abstract][Full Text] [Related]
19. An increase of the cardiothoracic ratio leads to a diagnosis of Bart's hydrops.
Phupong V
J Med Assoc Thai; 2006 Apr; 89(4):509-12. PubMed ID: 16696397
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive prenatal detection of haemoglobin Bart's disease by cardiothoracic ratio during the first trimester.
Zhen L; Pan M; Han J; Yang X; Ou YM; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():92-5. PubMed ID: 26262767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
